PT UBC Medical Indonesia Tbk (IDX:LABS)

Market Cap	576.70B +14.1%
Revenue (ttm)	176.64B +29.2%
Net Income	9.30B +324.8%
EPS	2.35 +153.2%
Shares Out	3.95B
PE Ratio	62.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	346,900
Average Volume	1,339,910
Open	147.00
Previous Close	146.00
Day's Range	146.00 - 148.00
52-Week Range	108.00 - 165.00
Beta	n/a
RSI	51.02
Earnings Date	Apr 9, 2026

About IDX:LABS

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. The company operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. It offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. The company was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 62
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2024, IDX:LABS's revenue was 147.64 billion, an increase of 8.00% compared to the previous year's 136.70 billion. Earnings were 2.95 billion, an increase of 34.84%.